Discover 1,922 paid clinical trials in Irving, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,922
Active & Responsive
A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)
for
Malignant Neoplasm
Location: Irving TX, Fairfax VA, Toronto, New Brunswick NJ,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07247110
Phase1, Recruiting
Active & Responsive
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
for
Prostate Cancer Castration-resistant Prostate Cancer,
Location: Irving TX, San Antonio TX, Grand Rapids MI,
Sponsor: MBrace Therapeutics
Sex: All
Age: 18+
Code: NCT07145255
Phase1, Phase2, Recruiting
Active & Responsive
A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors
for
Locally Advanced (Unresectable) or Metastatic Solid Tumors
Location: Dallas TX, Austin TX, Houston TX, San Antonio TX,
Sponsor: NEOK Bio, Inc.
Sex: All
Age: 18+
Code: NCT07612176
Phase1, Recruiting
Active & Responsive
A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
Get alerts for new trials in your area by subscribing now
Active & Responsive
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
for
Solid Tumor Malignancies, Colorectal Carcinoma,
Location: Dallas TX, San Antonio TX, St Louis MO, Omaha NE,
Sponsor: Tasca Therapeutics
Sex: All
Age: 18+
Code: NCT07030257
Phase1, Phase2, Recruiting
Active & Responsive
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
for
Solid Tumor, Non-Small-Cell Lung Cancer,
Location: Irving TX, Jefferson LA, St Louis MO, Atlanta GA,
Sponsor: Astellas Pharma Inc
Sex: All
Age: 18+
Code: NCT07094204
Phase1, Recruiting
Active & Responsive
A Study of ERAS-4001 in Patients With Advanced or Metastatic Solid Tumors.
for
Metastatic Solid Tumors
Location: Irving TX, Houston TX, San Antonio TX, Nashville TN,
Sponsor: Erasca, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07021898
Phase1, Recruiting
Active & Responsive
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
for
Breast Neoplasms
Location: Dallas TX, Fort Worth TX, Tyler TX, San Antonio TX,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06312176
Phase3, Recruiting
Active & Responsive
Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates
for
Liver Transplant
Location: Dallas TX, Omaha NE, Nashville TN, Chicago IL,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 18+
Code: NCT06075745
Phase2, Recruiting
Active & Responsive
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
for
PIK3CA Mutation, Solid Tumor, Adult,
Location: Dallas TX, Houston TX, St Louis MO, Nashville TN,